{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:13:35Z","timestamp":1792066415314,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS081041"],"award-info":[{"award-number":["U01 NS081041"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sedative, analgesia, and neuromuscular blocking (NMB) medications may be necessary in the acute management of pediatric severe traumatic brain injury (sTBI), yet limited data exist to guide their use. We aimed to describe the use of continuous infusions of these medications in children with sTBI, to determine temporal trends during the first week of management, and to evaluate associations with in-hospital mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a secondary analysis of the Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial (NCT04077411, 2014\u20132017), a prospective multicenter observational study of patients\u2009&lt;\u200918\u00a0years old with sTBI (Glasgow Coma Scale\u2009\u2264\u20098) who underwent intracranial pressure monitoring. Continuous analgesic, sedative, and NMB medication infusions administered in the first 7\u00a0days after sTBI were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data from 929 patients were analyzed with a median Glasgow Coma Scale of 6 (interquartile range 3\u20137), 14% hospital mortality. In the 7\u00a0days after intracranial pressure monitor placement, 866 (93%) patients received an opioid infusion, with 659 (71%) patients having received fentanyl. A total of 679 (73%) patients received benzodiazepine: 671 (72%) patients received midazolam. A total of 362 (39%) patients received NMB, with the most common being vecuronium, administered to 141 (15%) patients. Propofol was administered to 264 (28%) patients, alpha-2 agonist to 263 (28%) patients, and ketamine to 4 (0.43%) patients. The median number of infusions per patient was 2 (interquartile range 1\u20132), with the highest number on intensive care unit day 2. Morphine and dexmedetomidine infusions were used more often in survivors than nonsurvivors (33 vs. 16%, and 30 vs. 9%, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fentanyl and midazolam were the most common analgesic and sedative continuous infusions during acute pediatric sTBI management. Propofol and dexmedetomidine were used less frequently. Opioid (specifically morphine) and dexmedetomidine infusions were associated with survival. Larger studies are needed to determine the safest and most effective analgesia, sedation, and NMB medication strategy for children with sTBI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12028-025-02336-8","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T17:57:07Z","timestamp":1755280627000},"page":"745-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analgesia, Sedation, and Neuromuscular Blockade in Pediatric Severe Traumatic Brain Injury: Secondary Analysis of the \u201cApproaches and Decisions in Acute Pediatric TBI Trial\u201d (ADAPT)"],"prefix":"10.1007","volume":"43","author":[{"given":"Jennifer Clancy","family":"Laws","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran","family":"Rakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D. W.","family":"Buttram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-0353","authenticated-orcid":false,"given":"Michael Seth","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"4","key":"2336_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/PCC.0000000000001093","volume":"18","author":"EL Fink","year":"2017","unstructured":"Fink EL, Kochanek PM, Tasker RC, et al. International survey of critically ill children with acute neurologic insults: the prevalence of acute critical neurological disease in children: a global epidemiological assessment study*. Pediatr Crit Care Med. 2017;18(4):330. https:\/\/doi.org\/10.1097\/PCC.0000000000001093.","journal-title":"Pediatr Crit Care Med"},{"key":"2336_CR2","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics: Mortality Data on CDC WONDER. Accessed August 15, 2024. https:\/\/wonder.cdc.gov\/Deaths-by-Underlying-Cause.html"},{"issue":"25","key":"2336_CR3","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMsr1804754","volume":"379","author":"RM Cunningham","year":"2018","unstructured":"Cunningham RM, Walton MA, Carter PM. The major causes of death in children and adolescents in the United States. N Engl J Med. 2018;379(25):2468\u201375. https:\/\/doi.org\/10.1056\/NEJMsr1804754.","journal-title":"N Engl J Med"},{"key":"2336_CR4","unstructured":"TBI Data and Statistics|Concussion|Traumatic Brain Injury|CDC Injury Center. Accessed February 28, 2021. https:\/\/www.cdc.gov\/traumaticbraininjury\/data\/"},{"key":"2336_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.wneu.2016.03.045","volume":"91","author":"MC Dewan","year":"2016","unstructured":"Dewan MC, Mummareddy N, Wellons JC, Bonfield CM. Epidemiology of global pediatric traumatic brain injury: qualitative review. World Neurosurg. 2016;91:497-509.e1. https:\/\/doi.org\/10.1016\/j.wneu.2016.03.045.","journal-title":"World Neurosurg"},{"issue":"1","key":"2336_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00130478-200007000-00003","volume":"1","author":"PM Kochanek","year":"2000","unstructured":"Kochanek PM, Clark RS, Ruppel RA, Adelson PD, Bell MJ, Whalen MJ, Robertson CL, Satchell MA, Seidberg NA, Marion DW, Jenkins LW. Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: lessons learned from the bedside. Pediatr Crit Care Med. 2000;1(1):4\u201319.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2336_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/PCC.0000000000001735","volume":"20","author":"PM Kochanek","year":"2019","unstructured":"Kochanek PM, Tasker RC, Carney N, et al. Guidelines for the management of pediatric severe traumatic brain injury, third edition: update of the brain trauma foundation guidelines. Pediatr Crit Care Med. 2019;20(3):S1-82. https:\/\/doi.org\/10.1097\/PCC.0000000000001735.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2336_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/PCC.0000000000001737","volume":"20","author":"PM Kochanek","year":"2019","unstructured":"Kochanek PM, Tasker RC, Bell MJ, et al. Management of pediatric severe traumatic brain injury: 2019 consensus and guidelines-based algorithm for first and second tier therapies. Pediatr Crit Care Med. 2019;20(3):269\u201379. https:\/\/doi.org\/10.1097\/PCC.0000000000001737.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2336_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/PCC.0000000000000610","volume":"17","author":"SL Shein","year":"2016","unstructured":"Shein SL, Ferguson NM, Kochanek PM, et al. Effectiveness of pharmacological therapies for intracranial hypertension in children with severe traumatic brain injury-results from an automated data collection system time-synched to drug administration. Pediatr Crit Care Med. 2016;17(3):236\u201345. https:\/\/doi.org\/10.1097\/PCC.0000000000000610.","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2336_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/CCM.000000000000155","volume":"44","author":"TP Welch","year":"2016","unstructured":"Welch TP, Wallendorf MJ, Kharasch ED, Leonard JR, Doctor A, Pineda JA. Fentanyl and midazolam are ineffective in reducing episodic intracranial hypertension in severe pediatric traumatic brain injury. Crit Care Med. 2016;44(4):809\u201318. https:\/\/doi.org\/10.1097\/CCM.000000000000155.","journal-title":"Crit Care Med"},{"issue":"4","key":"2336_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/CCM.0000000000006106","volume":"52","author":"SY Liu","year":"2024","unstructured":"Liu SY, Kelly-Hedrick M, Temkin N, et al. Association of early dexmedetomidine utilization with clinical and functional outcomes following moderate-severe traumatic brain injury: a transforming clinical research and knowledge in traumatic brain injury study*. Crit Care Med. 2024;52(4):607\u201317. https:\/\/doi.org\/10.1097\/CCM.0000000000006106.","journal-title":"Crit Care Med"},{"key":"2336_CR12","unstructured":"Carney N, Totten AM, Ullman JS, et al. Guidelines for the Management of Severe Traumatic Brain Injury 4th Edition. Published online 2016"},{"issue":"7","key":"2336_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/children9071092","volume":"9","author":"NM Ferguson","year":"2022","unstructured":"Ferguson NM, Rebsamen S, Field AS, et al. Magnetic resonance imaging findings in infants with severe traumatic brain injury and associations with abusive head trauma. Children. 2022;9(7): 1092. https:\/\/doi.org\/10.3390\/children9071092.","journal-title":"Children"},{"issue":"3","key":"2336_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/PCC.0000000000003417","volume":"25","author":"CR McNamara","year":"2024","unstructured":"McNamara CR, Kalinowski A, Horvat CM, et al. New functional impairment after hospital discharge by traumatic brain injury mechanism in under 3-years-old admitted to the PICU in a single center retrospective study. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2024;25(3):250\u20138. https:\/\/doi.org\/10.1097\/PCC.0000000000003417.","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"4","key":"2336_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/PCC.0000000000000344","volume":"16","author":"KH Chin","year":"2015","unstructured":"Chin KH, Bell MJ, Wisniewski SR, et al. Effect of Administration of neuromuscular blocking agents in children with severe traumatic brain injury on acute complication rates and outcomes: a secondary analysis from a randomized, controlled trial of therapeutic hypothermia. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2015;16(4):352\u20138. https:\/\/doi.org\/10.1097\/PCC.0000000000000344.","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"11","key":"2336_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1089\/neu.1998.15.985","volume":"15","author":"EA Bedell","year":"1998","unstructured":"Bedell EA, DeWitt DS, Prough DS. Fentanyl infusion preserves cerebral blood flow during decreased arterial blood pressure after traumatic brain injury in cats. J Neurotrauma. 1998;15(11):985\u201392. https:\/\/doi.org\/10.1089\/neu.1998.15.985.","journal-title":"J Neurotrauma"},{"issue":"2","key":"2336_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00000542-198202000-00003","volume":"56","author":"CE Rosow","year":"1982","unstructured":"Rosow CE, Moss J, Philbin DM, Savarese JJ. Histamine release during morphine and fentanyl anesthesia. Anesthesiology. 1982;56(2):93\u20136. https:\/\/doi.org\/10.1097\/00000542-198202000-00003.","journal-title":"Anesthesiology"},{"issue":"12","key":"2336_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.ccm.0000475001.16167.bc","volume":"43","author":"A Guardenier","year":"2015","unstructured":"Guardenier A, Peterson B, Hilfiker M, Shellington D. 1170: acute renal failure in pediatric patients after moderate to severe traumatic brain injury. Crit Care Med. 2015;43(12):294. https:\/\/doi.org\/10.1097\/01.ccm.0000475001.16167.bc.","journal-title":"Crit Care Med"},{"issue":"1","key":"2336_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.ccm.0000731100.40267.83","volume":"49","author":"S Nathan","year":"2021","unstructured":"Nathan S, Sethna C, Schleien C, Schneider J. 1303: Cerebral-renal relations in pediatric traumatic brain injury. Crit Care Med. 2021;49(1):657. https:\/\/doi.org\/10.1097\/01.ccm.0000731100.40267.83.","journal-title":"Crit Care Med"},{"issue":"2","key":"2336_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00000542-198802000-00010","volume":"68","author":"JE Fleischer","year":"1988","unstructured":"Fleischer JE, Milde JH, Moyer TP, Michenfelder JD. Cerebral effects of high-dose midazolam and subsequent reversal with Ro 15\u20131788 in dogs. Anesthesiology. 1988;68(2):234\u201342. https:\/\/doi.org\/10.1097\/00000542-198802000-00010.","journal-title":"Anesthesiology"},{"key":"2336_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/637171","volume":"2012","author":"O Flower","year":"2012","unstructured":"Flower O, Hellings S. Sedation in traumatic brain injury. Emerg Med Int. 2012;2012: 637171. https:\/\/doi.org\/10.1155\/2012\/637171.","journal-title":"Emerg Med Int"},{"key":"2336_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainresbull.2021.08.010","volume":"176","author":"S Rahimi","year":"2021","unstructured":"Rahimi S, Dadfar B, Tavakolian G, Asadi Rad A, Rashid Shabkahi A, Siahposht-Khachaki A. Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system. Brain Res Bull. 2021;176:103\u201311. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.08.010.","journal-title":"Brain Res Bull"},{"issue":"6","key":"2336_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3171\/jns.1999.90.6.1042","volume":"90","author":"DF Kelly","year":"1999","unstructured":"Kelly DF, Goodale DB, Williams J, et al. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg. 1999;90(6):1042\u201352. https:\/\/doi.org\/10.3171\/jns.1999.90.6.1042.","journal-title":"J Neurosurg"},{"issue":"Suppl 2","key":"2336_CR24","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.surneu.2006.08.028","volume":"66","author":"WT Chiu","year":"2006","unstructured":"Chiu WT, Lin TJ, Lin JW, Huang SJ, Chang CK, Chen HY. Multicenter evaluation of propofol for head-injured patients in Taiwan. Surg Neurol. 2006;66(Suppl 2):S37-42. https:\/\/doi.org\/10.1016\/j.surneu.2006.08.028.","journal-title":"Surg Neurol"},{"issue":"7","key":"2336_CR25","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2044.2007.05055.x","volume":"62","author":"PCA Kam","year":"2007","unstructured":"Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62(7):690\u2013701. https:\/\/doi.org\/10.1111\/j.1365-2044.2007.05055.x.","journal-title":"Anaesthesia"},{"issue":"9","key":"2336_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1345\/aph.1A321","volume":"36","author":"TM Kang","year":"2002","unstructured":"Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother. 2002;36(9):1453\u20136. https:\/\/doi.org\/10.1345\/aph.1A321.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"2336_CR27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1542\/peds.112.4.1002","volume":"112","author":"K Felmet","year":"2003","unstructured":"Felmet K, Nguyen T, Clark RS, Orr D, Carcillo J. The FDA warning against prolonged sedation with propofol in children remains warranted. Pediatrics. 2003;112(4):1002\u20133. https:\/\/doi.org\/10.1542\/peds.112.4.1002.","journal-title":"Pediatrics"},{"issue":"2","key":"2336_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002873","volume":"23","author":"HAB Smith","year":"2022","unstructured":"Smith HAB, Besunder JB, Betters KA, et al. 2022 Society of critical care medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically Ill pediatric patients with consideration of the icu environment and early mobility. Pediatr Crit Care Med. 2022;23(2): e74. https:\/\/doi.org\/10.1097\/PCC.0000000000002873.","journal-title":"Pediatr Crit Care Med"},{"issue":"22","key":"2336_CR29","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644\u201353. https:\/\/doi.org\/10.1001\/jama.298.22.2644.","journal-title":"JAMA"},{"issue":"1","key":"2336_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12871-022-01822-2","volume":"22","author":"J Xu","year":"2022","unstructured":"Xu J, Xiao Q. Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis. BMC Anesthesiol. 2022;22(1):280. https:\/\/doi.org\/10.1186\/s12871-022-01822-2.","journal-title":"BMC Anesthesiol"},{"issue":"8","key":"2336_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1469-8749.2012.04322.x","volume":"54","author":"KA Kirk","year":"2012","unstructured":"Kirk KA, Shoykhet M, Jeong JH, et al. Dysautonomia after pediatric brain injury. Dev Med Child Neurol. 2012;54(8):759\u201364. https:\/\/doi.org\/10.1111\/j.1469-8749.2012.04322.x.","journal-title":"Dev Med Child Neurol"},{"key":"2336_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231194708","author":"CR Jerousek","year":"2024","unstructured":"Jerousek CR, Reinert JP. The role of dexmedetomidine in paroxysmal sympathetic hyperactivity: a systematic review. Ann Pharmacother. 2024. https:\/\/doi.org\/10.1177\/10600280231194708.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"2336_CR33","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/BJA\/44.12.1298","volume":"44","author":"J Gibbs","year":"1972","unstructured":"Gibbs J. The effect of intravenous ketamine on cerebrospinal fluid pressure. Br J Anaesth. 1972;44(12):1298\u2013302. https:\/\/doi.org\/10.1093\/BJA\/44.12.1298.","journal-title":"Br J Anaesth"},{"key":"2336_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197201000-00023","author":"WF List","year":"1972","unstructured":"List WF, Crumrine RS, Cascorbi HF, Weiss MH. Increased cerebrospinal fluid pressure after ketamine. Anesthesiology. 1972. https:\/\/doi.org\/10.1097\/00000542-197201000-00023.","journal-title":"Anesthesiology"},{"issue":"4","key":"2336_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.20408\/jti.2023.0034","volume":"36","author":"AJ Peters","year":"2023","unstructured":"Peters AJ, Khan SA, Koike S, Rowell S, Schreiber M. Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis. J Trauma Inj. 2023;36(4):354\u201361. https:\/\/doi.org\/10.20408\/jti.2023.0034.","journal-title":"J Trauma Inj"},{"issue":"1","key":"2336_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3171\/2009.1.PEDS08319","volume":"4","author":"G Bar-Joseph","year":"2009","unstructured":"Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension: clinical article. J Neurosurg Pediatr. 2009;4(1):40\u20136. https:\/\/doi.org\/10.3171\/2009.1.PEDS08319.","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"2336_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/CCM.0000000000005806","volume":"51","author":"JC Laws","year":"2023","unstructured":"Laws JC, Vance EH, Betters KA, et al. Acute effects of ketamine on intracranial pressure in children with severe traumatic brain injury*. Crit Care Med. 2023;51(5):563\u201372. https:\/\/doi.org\/10.1097\/CCM.0000000000005806.","journal-title":"Crit Care Med"},{"issue":"3","key":"2336_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s12028-023-01859-2","volume":"40","author":"M Jacobwitz","year":"2024","unstructured":"Jacobwitz M, Mulvihill C, Kaufman MC, et al. A comparison of ketamine and midazolam as first-line anesthetic infusions for pediatric status epilepticus. Neurocrit Care. 2024;40(3):984\u201395. https:\/\/doi.org\/10.1007\/s12028-023-01859-2.","journal-title":"Neurocrit Care"},{"issue":"8","key":"2336_CR39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/PCC.0000000000003526","volume":"25","author":"N Ahmed","year":"2024","unstructured":"Ahmed N, Russo L, Kuo YH. Levetiracetam or phenytoin as prophylaxis for status epilepticus: secondary analysis of the \u201capproaches and decisions in acute pediatric traumatic brain injury trial\u201d (ADAPT) dataset, 2014\u20132017. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2024;25(8):710\u20139. https:\/\/doi.org\/10.1097\/PCC.0000000000003526.","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"14","key":"2336_CR40","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1089\/neu.2016.4793","volume":"34","author":"S Murphy","year":"2017","unstructured":"Murphy S, Thomas NJ, Gertz SJ, et al. Tripartite stratification of the glasgow coma scale in children with severe traumatic brain injury and mortality: an analysis from a multi-center comparative effectiveness study. J Neurotrauma. 2017;34(14):2220\u20139. https:\/\/doi.org\/10.1089\/neu.2016.4793.","journal-title":"J Neurotrauma"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02336-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T22:51:23Z","timestamp":1764111083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02336-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02336-8","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each author has completed an International Committee of Medical Journal Editors Conflict of\u00a0Interest form, included with this submission. We report no significant conflicts of interest. Dr. Buttram served as a site Principal Investigator for the original data collection of the Approaches and Decisions for Acute Pediatric TBI Trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The institutional review boards of Vanderbilt University Medical Center and Phoenix Children\u2019s Hospital determined our investigation as nonhuman study participants research not requiring informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}